- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03008174
Early Speech With One-Way Speaking Valve in Tracheostomy Patients
January 14, 2020 updated by: Johns Hopkins University
Early Speech With One-Way Speaking Valve in Tracheostomy Patients - Pilot Study
Patients with tracheostomy who are on and off of mechanical ventilation initially lose the ability to speak, and the use of one-way speaking valves (OWSV) is one method of restoring speech in these patients.
Patients with tracheostomy who experience loss of speech report frustration and feelings of confinement from patients' communication impairment, therefore investigators would like to restore speech in these patients as soon as it is safe to do so.
However, there is currently little known in the literature about the timing of the use of OWSV in patients with tracheostomy.
Therefore, the investigators propose a pre-test post-test clinical trial pilot study to investigate the safety of early use of OWSV in patients undergoing a percutaneous tracheostomy.
Study aims are to identify patients who would benefit from the early use of OWSV and to determine the effects of early use of OWSV on speech and clinical outcomes.
To achieve these aims, patients who undergo percutaneous tracheostomy will be screened, and patients meeting screening criteria will be randomized into intervention and control groups.
The intervention group will receive early speech-language pathology (SLP) evaluation and OWSV trial at 12-24 hours following tracheostomy procedure, and the control group will receive standard SLP evaluation and OWSV trial at 48-60 hours following tracheostomy procedure.
Intervention and control groups will been compared on speech and clinical outcomes measures from pre-test at 12-24 hours following tracheostomy and post-test at 48-60 hours following tracheostomy and characteristics of patients who successfully tolerate early OWSV use will be identified.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- The Johns Hopkins Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient who received a percutaneous tracheostomy
- Glasgow Coma Scale score ≥9
- Confusion Assessment Method -ICU (CAM-ICU): negative
- Richmond Agitation Sedation Scale (RASS): -1 to +1
- Able to understand English
Exclusion Criteria:
- Open tracheostomy
- Laryngectomy
- Presently using OWSV or capped trach
- Foam-filled cuffed tracheostomy tube
- Presence of known severe airway obstruction
- Presence of post-operative bleeding requiring transfusion or packing
- Presence of air-leak around the cuff resulting in respiratory decompensation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
|
The OWSV assessment by speech language pathologists will be completed at 12-24 hours following percutaneous tracheostomy procedure, which is earlier than the current standard of care of 48 hours or later.
|
NO_INTERVENTION: Control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Speech Intelligibility as Assessed by Speech Intelligibility Test Score
Time Frame: Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible).
|
Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Speech Intelligibility as Assessed by Speech Intelligibility Test Score
Time Frame: Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible).
|
Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Speech Intelligibility as Assessed by Speech Intelligibility Test Score
Time Frame: Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
|
Speech intelligibility test scores will be reported in percentages (Percentage of words that were intelligible).
|
Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores
Time Frame: Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores.
QOL scores will be reported on a scale of 0 - 100.
The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life.
|
Up to 24 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores
Time Frame: Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores.
QOL scores will be reported on a scale of 0 - 100.
The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life.
|
Between 25 and 60 hours after percutaneous tracheostomy procedure (assessed once within the period)
|
Quality of Life as Assessed by Quality of Life in Mechanically Ventilated Patients Scores
Time Frame: Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
|
Quality of life as assessed by Quality of Life in Mechanically Ventilated Patients Scores.
QOL scores will be reported on a scale of 0 - 100.
The lower the score, the poorer the quality of life is, and the higher the score, the better the quality of life.
|
Between 61 hours and 21 days after percutaneous tracheostomy procedure (assessed once within the period)
|
Number of Participants With Bleeding
Time Frame: At the time of use of speaking valve up to 24hours after percutaneous tracheostomy procedure
|
Bleeding will be reported as present or absent.
|
At the time of use of speaking valve up to 24hours after percutaneous tracheostomy procedure
|
Number of Participants With Bleeding
Time Frame: At the time of use of speaking valve between 25 and 60 hours after percutaneous tracheostomy procedure
|
Bleeding will be reported as present or absent.
|
At the time of use of speaking valve between 25 and 60 hours after percutaneous tracheostomy procedure
|
Number of Participants With Bleeding
Time Frame: At the time of use of speaking valve between 61 hours and 21 days after percutaneous tracheostomy procedure
|
Bleeding will be reported as present or absent.
|
At the time of use of speaking valve between 61 hours and 21 days after percutaneous tracheostomy procedure
|
Intensive Care Unit (ICU) Length of Stay
Time Frame: At the time of discharge, up to 4 months
|
ICU length of stay will be reported in days.
|
At the time of discharge, up to 4 months
|
Hospital Length of Stay
Time Frame: At the time of discharge, up to 4 months
|
Hospital length of stay will be reported in days.
|
At the time of discharge, up to 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Vinciya Pandian, PhD, MSN, ACNP, Johns Hopkins University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hess DR, Altobelli NP. Tracheostomy tubes. Respir Care. 2014 Jun;59(6):956-71; discussion 971-3. doi: 10.4187/respcare.02920.
- Mehta AB, Syeda SN, Bajpayee L, Cooke CR, Walkey AJ, Wiener RS. Trends in Tracheostomy for Mechanically Ventilated Patients in the United States, 1993-2012. Am J Respir Crit Care Med. 2015 Aug 15;192(4):446-54. doi: 10.1164/rccm.201502-0239OC.
- Carroll SM. Silent, slow lifeworld: the communication experience of nonvocal ventilated patients. Qual Health Res. 2007 Nov;17(9):1165-77. doi: 10.1177/1049732307307334.
- Foster A. More than nothing: the lived experience of tracheostomy while acutely ill. Intensive Crit Care Nurs. 2010 Feb;26(1):33-43. doi: 10.1016/j.iccn.2009.09.004. Epub 2009 Nov 11.
- Freeman BD, Isabella K, Lin N, Buchman TG. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients. Chest. 2000 Nov;118(5):1412-8. doi: 10.1378/chest.118.5.1412.
- Pandian V, Thompson CB, Feller-Kopman DJ, Mirski MA. Development and validation of a quality-of-life questionnaire for mechanically ventilated ICU patients. Crit Care Med. 2015 Jan;43(1):142-8. doi: 10.1097/CCM.0000000000000552.
- Martin KA, Cole TDK, Percha CM, Asanuma N, Mattare K, Hager DN, Brenner MJ, Pandian V. Standard versus Accelerated Speaking Valve Placement after Percutaneous Tracheostomy: A Randomized Controlled Feasibility Study. Ann Am Thorac Soc. 2021 Oct;18(10):1693-1701. doi: 10.1513/AnnalsATS.202010-1282OC.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 5, 2016
Primary Completion (ACTUAL)
November 28, 2019
Study Completion (ACTUAL)
December 5, 2019
Study Registration Dates
First Submitted
November 28, 2016
First Submitted That Met QC Criteria
December 28, 2016
First Posted (ESTIMATE)
January 2, 2017
Study Record Updates
Last Update Posted (ACTUAL)
January 23, 2020
Last Update Submitted That Met QC Criteria
January 14, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00080981
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Will not be sharing data
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Failure
-
Poitiers University HospitalRecruitingAcute Respiratory Failure | Hypoxemic Respiratory FailureFrance
-
Catholic University of the Sacred HeartFisher and Paykel HealthcareCompletedWeaning Failure | Acute Respiratory FailureFrance, Greece, Italy, Spain
-
Hemovent GmbHMAXIS Medical, LLCActive, not recruitingRespiratory Failure | Cardiac Failure | Cardio-Respiratory FailureGermany
-
Hospital Clinic of BarcelonaCompletedHypercapnic Respiratory Failure | Hypoxemic Respiratory FailureSpain
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Efficacy Care R&D LtdMemorial Hermann Hospital; CRG Medical, Inc.UnknownShock | Shock, Septic | Respiratory Failure | Respiratory Distress Syndrome | Shock, Cardiogenic | Acute Cardiac Failure | Acute Respiratory Failure | Acute Kidney Failure | Multi Organ Failure | Respiratory Arrest | Acute Respiratory Failure With Hypoxia | Acute Respiratory Failure Requiring Reintubation | Acute... and other conditionsUnited States
-
Siriraj HospitalRecruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory FailureThailand
-
Fisher and Paykel HealthcareCentre hospitalier de l'Université de Montréal (CHUM); Institut universitaire...Not yet recruitingAcute Hypoxemic Respiratory Failure | Acute Hypercapnic Respiratory Failure
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
-
University Hospital, MotolCompletedRefractory Respiratory FailureCzechia
Clinical Trials on Early one-way speaking valve (OWSV) assessment
-
Rush University Medical CenterWithdrawnTracheostomy ComplicationUnited States
-
Centro Universitário Augusto MottaCompletedPulmonary Volumes After Cardiac Surgery
-
Cardiff and Vale University Health BoardCompletedIntensive CareUnited Kingdom
-
Radboud University Medical CenterTerminatedLiver Neoplasms | Colorectal NeoplasmsNetherlands
-
West China HospitalEnrolling by invitationLong-term-opioid-free AnesthesiaChina
-
Hospital JP GarrahanHospital Pereyra Rosell, Montevideo, UruguayRecruitingPediatric Hodgkin's DiseaseArgentina